(Q51004094)

26 March 2018

title

Insulin-like growth factor-I decreases serum lipoprotein (a) during long-term treatment of patients with Laron syndrome. (English)

1 reference

26 March 2018

1 reference

Laron Z

1

1 reference

26 March 2018

Wang XL

2

1 reference

26 March 2018

Klinger B

3

1 reference

26 March 2018

Silbergeld A

4

1 reference

26 March 2018

Wilcken DE

5

1 reference

26 March 2018

publication date

1 October 1996

1 reference

26 March 2018

published in

Metabolism

1 reference

26 March 2018

volume

45

1 reference

26 March 2018

issue

10

1 reference

26 March 2018

page(s)

1263-1266

1 reference

26 March 2018

The mysteries of lipoprotein(a)

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990245-0

Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990245-0

A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990245-0

Lipoprotein(a) and apolipoproteins B and A-1 in children and coronary vascular events in their grandparents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990245-0

Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990245-0

Effect of insulin treatment on serum lipoprotein(a) in non-insulin-dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990245-0

Triiodothyronine rapidly lowers plasma lipoprotein (a) in hypothyroid subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990245-0

Biochemical and hormonal changes induced by one week of administration of rIGF-I to patients with Laron type dwarfism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990245-0

IGF-I treatment of adult patients with Laron syndrome: preliminary results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990245-0

Classification of growth hormone insensitivity syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990245-0

An indirect sandwich ELISA for LP(a) in serum and dried blood spots

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990245-0

Renal function in Laron syndrome patients treated by insulin-like growth factor-I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990245-0

Body fat in Laron syndrome patients: effect of insulin-like growth factor I treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990245-0

Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin-like growth factor-I treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990245-0

International Lp(a) standardization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2896%2990245-0

10.1016/S0026-0495(96)90245-0

7 January 2021

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018